Ledger.Open graph →
SEC Form D · filed April 3, 2018

NEKTAR THERAPEUTICS

Offering
$850.0M
Sold
$850.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Howard W. Robin · San Francisco, CAExec · DirectorStephen K. Doberstein · San Francisco, CAExecRoy A. Whitfield · San Francisco, CADirectorJeff R. Ajer · San Francisco, CADirectorLutz A. Lingnau · San Francisco, CADirectorGil M. Labrucherie · San Francisco, CAExecManinder K. Hora · San Francisco, CAExecJohn K. Nicholson · San Francisco, CAExecJillian B. Thomsen · San Francisco, CAExecChristopher A. Kuebler · San Francisco, CADirectorDennis L. Winger · San Francisco, CADirectorR. Scott R. Greer · San Francisco, CADirectorRobert B. Chess · San Francisco, CADirectorLutz A. Lingnau · San Francisco, CADirectorHoward W. Robin · San Francisco, CAExec · DirectorGil M. Labrucherie · San Francisco, CAExecManinder K. Hora · San Francisco, CAExecStephen K. Doberstein · San Francisco, CAExecJohn K. Nicholson · San Francisco, CAExecRoy A. Whitfield · San Francisco, CADirectorJillian B. Thomsen · San Francisco, CAExecChristopher A. Kuebler · San Francisco, CADirectorDennis L. Winger · San Francisco, CADirectorJeff R. Ajer · San Francisco, CADirectorR. Scott R. Greer · San Francisco, CADirectorRobert B. Chess · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗